Circular RNA 0001073 Attenuates Malignant Biological Behaviours in Breast Cancer Cell and Is Delivered by Nanoparticles to Inhibit Mice Tumour Growth
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in OncoTargets and Therapy
- Vol. 13, 6157-6169
- https://doi.org/10.2147/OTT.S248822
Abstract
Background: Circular RNAs (circRNAs) are a special class of noncoding RNAs that are involved in gene regulation and compete with mRNA for miRNA binding sites. The roles of circRNAs in cancer, especially breast cancer (BC), are poorly understood. Materials and Methods: The expression levels of circRNA 0001073 (circ-1073) in BC cells (BCCs) and tissues and peritumoural tissues were detected by real-time quantitative reverse transcription-polymerase chain reaction. Kaplan-Meier analysis and receiver operat- ing characteristic curves were used to evaluate relapse-free survival (RFS) and the diagnostic value of circ-1073 for BC, respectively. The biological functions of circ-1073 were deter- mined by cell counting kit-8 assays, colony formation assays, flow cytometry, wound-healing assays, transwell assays, and xenograft model studies. RNA immunoprecipitation assays were conducted to identify the connection between circ-1073 and human antigen R (HuR). Results: Low circ-1073 expression was discovered in BCCs and BC tissues compared with normal mammary epithelial cells and peritumoural tissues, respectively. Circ-1073 down- regulation was signi ficantly associated with an unfavourable prognosis, including a shorter RFS, in BC patients. Circ-1073 is a valuable diagnostic biomarker for BC. Circ-1073 overexpression signi ficantly inhibited BCC proliferation and induced apoptosis by increasing Cleaved Caspase-3/9 levels. Moreover, circ-1073 upregulation signi ficantly suppressed cell mobility and epithelial-mesenchymal transition. Notably, xenograft tumour growth was inhibited by the intratumoural injection of nanoparticles containing the circ-1073 plasmid or by circ-1073 overexpression, and this inhibition was accompanied by HuR upregulation. Conclusion: Circ-1073 functions as a tumour suppressor in BC, suggesting its potential as a novel therapeutic target in BC.This publication has 51 references indexed in Scilit:
- Cell-Type Specific Features of Circular RNA ExpressionPLoS Genetics, 2013
- Gdf6 induces commitment of pluripotent mesenchymal C3H10T1/2 cells to the adipocyte lineageThe FEBS Journal, 2013
- A mesoporous silica nanoparticle – PEI – Fusogenic peptide system for siRNA delivery in cancer therapyBiomaterials, 2013
- Circular RNAs are abundant, conserved, and associated with ALU repeatsRNA, 2012
- Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancersNano Today, 2012
- Targeted Polymeric Micelles for siRNA Treatment of Experimental Cancer by Intravenous InjectionACS Nano, 2012
- Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesisCell Cycle, 2010
- Chromosome 8p Deletions and 8q Gains are Associated with Tumor Progression and Poor Prognosis in Prostate CancerClinical Cancer Research, 2010
- Splicing of a circular yeast pre-mRNAin vitroNucleic Acids Research, 1995
- Circular transcripts of the testis-determining gene Sry in adult mouse testisCell, 1993